Insulet Corporation Interest Expense 2011-2025 | PODD

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Insulet Corporation

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.5 M	2.2 M	-1.1 M	61.7 M	48.1 M	34.6 M	28.9 M	21.2 M	14.4 M	12.7 M	-1.22 M	1.43 M	-	-14.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
61.7 M	-14.6 M	15.6 M

Quarterly Interest Expense Insulet Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.1 M	1.3 M	-2.3 M	-	-3.4 M	-1.8 M	10.7 M	-	700 K	-200 K	9.4 M	-	9.2 M	9.1 M	9 M	-	16.4 M	16.6 M	13.6 M	-	11.9 M	11.8 M	11.6 M	-	9.4 M	7.7 M	6.6 M	-	6.85 M	7.29 M	1.68 M	-	556 K	488 K	434 K	-	211 K	129 K	170 K	-	21 K	28 K	27 K	-	-677 K	300 K	300 K	-	100 K	-	-	-	-3.92 M	-3.89 M	-3.84 M	-	-3.79 M	-4.51 M	-2.58 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16.6 M	-4.51 M	3.6 M

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Abiomed ABMD	58.7 M	-	-	$ 17.2 B	USA
Acutus Medical AFIB	5.66 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Apyx Medical Corporation APYX	2.48 M	$ 3.47	-3.61 %	$ 120 M	USA
Boston Scientific Corporation BSX	305 M	$ 96.06	-0.04 %	$ 141 B	USA
Cognyte Software Ltd. CGNT	-1.61 M	$ 9.35	-1.99 %	$ 671 M	Israel
Bio-Rad Laboratories BIO	48.9 M	$ 303.76	0.52 %	$ 8.57 B	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
BioSig Technologies BSGM	23 K	-	37.08 %	$ 85.7 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Bruker Corporation BRKR	-38.2 M	$ 47.89	-0.48 %	$ 7.14 K	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Abbott Laboratories ABT	376 M	$ 124.72	-0.1 %	$ 217 B	USA
EDAP TMS S.A. EDAP	232 K	$ 3.3	11.09 %	$ 123 M	France
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Second Sight Medical Products EYES	1.19 M	-	-0.97 %	$ 54.4 M	USA
LivaNova PLC LIVN	1.01 M	$ 62.92	-0.25 %	$ 3.41 B	Britain
Align Technology ALGN	7.68 M	$ 158.62	0.49 %	$ 11.9 B	USA
NanoVibronix NAOV	135 K	-	-	$ 1.08 M	USA
Accuray Incorporated ARAY	13 M	$ 0.83	-3.49 %	$ 85.3 M	USA
LENSAR LNSR	660 K	$ 12.03	0.17 %	$ 139 M	USA
IRadimed Corporation IRMD	164 K	$ 97.53	0.48 %	$ 1.24 B	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	-40 K	$ 14.04	-3.13 %	$ 379 M	USA
FONAR Corporation FONR	347 K	$ 14.51	-0.13 %	$ 95.1 M	USA
AxoGen AXGN	-199 K	$ 32.87	0.7 %	$ 1.45 B	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
CONMED Corporation CNMD	37.3 M	$ 40.89	2.12 %	$ 1.26 B	USA
OrthoPediatrics Corp. KIDS	-1.07 M	$ 17.36	-0.29 %	$ 401 M	USA
Globus Medical GMED	2.2 M	$ 88.38	-0.15 %	$ 12 B	USA
Integra LifeSciences Holdings Corporation IART	3.94 M	$ 12.65	-0.08 %	$ 974 M	USA
Aziyo Biologics AZYO	5.8 M	-	1.37 %	$ 20.5 M	USA
Aethlon Medical AEMD	10.1 K	$ 2.58	3.61 %	$ 4.03 M	USA
Myomo MYO	21.1 K	$ 1.02	-	$ 7.19 M	USA